A detailed history of Carret Asset Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Carret Asset Management, LLC holds 40,385 shares of OGN stock, worth $750,353. This represents 0.1% of its overall portfolio holdings.

Number of Shares
40,385
Previous 40,825 1.08%
Holding current value
$750,353
Previous $767,000 8.87%
% of portfolio
0.1%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$17.45 - $21.96 $7,678 - $9,662
-440 Reduced 1.08%
40,385 $835,000
Q1 2024

Apr 18, 2024

SELL
$13.78 - $18.8 $225,316 - $307,398
-16,351 Reduced 28.6%
40,825 $767,000
Q4 2023

Feb 02, 2024

SELL
$10.95 - $17.32 $325,477 - $514,819
-29,724 Reduced 34.2%
57,176 $824,000
Q3 2023

Oct 12, 2023

SELL
$16.59 - $23.77 $63,340 - $90,753
-3,818 Reduced 4.21%
86,900 $1.51 Million
Q2 2023

Jul 25, 2023

BUY
$19.27 - $24.63 $14,664 - $18,743
761 Added 0.85%
90,718 $1.89 Million
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $25,168 - $37,694
1,175 Added 1.32%
89,957 $2.12 Million
Q4 2022

Jan 10, 2023

SELL
$23.31 - $28.61 $18,368 - $22,544
-788 Reduced 0.88%
88,782 $2.48 Million
Q3 2022

Oct 11, 2022

SELL
$23.4 - $34.25 $7,137 - $10,446
-305 Reduced 0.34%
89,570 $2.1 Million
Q2 2022

Aug 04, 2022

SELL
$31.66 - $38.9 $29,127 - $35,788
-920 Reduced 1.01%
89,875 $3.03 Million
Q1 2022

Apr 13, 2022

SELL
$30.45 - $39.36 $14,311 - $18,499
-470 Reduced 0.51%
90,795 $3.17 Million
Q4 2021

Jan 10, 2022

SELL
$28.67 - $37.13 $8,658 - $11,213
-302 Reduced 0.33%
91,265 $2.78 Million
Q3 2021

Oct 27, 2021

BUY
$28.63 - $35.64 $145,984 - $181,728
5,099 Added 5.9%
91,567 $3 Million
Q2 2021

Jul 14, 2021

BUY
$28.45 - $38.0 $2.46 Million - $3.29 Million
86,468 New
86,468 $2.62 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.73B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Carret Asset Management, LLC Portfolio

Follow Carret Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.